Literature DB >> 12457764

Anthrax X-rayed: new opportunities for biodefence.

Milton T Stubbs1.   

Abstract

Bacillus anthracis, the agent responsible for inhalation anthrax, exerts its lethal effects via the production of anthrax toxin (protective antigen, lethal factor and oedema factor); anthrax kills because the toxin overwhelms the patient before innate host defence systems have a chance to eradicate the invaders. Structural studies on these three components provide a starting point for the design of novel drugs to neutralize toxin action, yielding a valuable adjunct to conventional antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457764     DOI: 10.1016/s0165-6147(02)02127-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  4 in total

1.  Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.

Authors:  Sherida L Johnson; Dawoon Jung; Martino Forino; Ya Chen; Arnold Satterthwait; Dmitry V Rozanov; Alex Y Strongin; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

Review 2.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

Review 3.  Furin Protease: From SARS CoV-2 to Anthrax, Diabetes, and Hypertension.

Authors:  Kara Fitzgerald
Journal:  Perm J       Date:  2020

Review 4.  Virus entry: molecular mechanisms and biomedical applications.

Authors:  Dimiter S Dimitrov
Journal:  Nat Rev Microbiol       Date:  2004-02       Impact factor: 60.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.